Where is Gameto's headquarters?

Gameto is located in New York, New York, United States.

Who invested in Gameto?

Gameto has 30 investors including Bold Capital Partners And Ingeborg Investments.

When was the last funding round for Gameto?

Gameto closed its last funding round on obfuscated from a Series C round.

Who are Gameto's competitors?

Alternatives and possible competitors to Gameto may include Thermo Fisher Scientific, Ferring, And AiVF.

Gameto - Growth Outlook

Growth Outlook

Growth Score

updated Apr 26, 2026

-10 pts

in past quarter

Growth Performance Over Time

Score

Trend

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

Growth Insight

See this Growth Insight

Gameto is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Companies with Similar Growth

Organization Name	Growth Score	Industries	Headquarters Location	Description
ARCH Venture Partners	84	Finance, Financial Services, Incubators, Life Science, Venture Capital	Chicago, Illinois, United States	ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Massive Bio	85	Artificial Intelligence (AI), Big Data, Biotechnology, Clinical Trials, Health Care, Machine Learning, Natural Language Processing	Boca Raton, Florida, United States	Massive Bio is building the world's largest global real time cancer registry with patient consented clinical and genomic data.
Apogee Therapeutics	89	Biotechnology, Life Science, Medical, Therapeutics	San Francisco, California, United States	Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
Nuvalent	87	Biotechnology, Life Science, Therapeutics	Cambridge, Massachusetts, United States	Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.
Isomorphic Labs	91	Artificial Intelligence (AI), Biotechnology, Life Science, Medical	London, England, United Kingdom	Isomorphic Labs is an AI-first drug design and development company that transforms drug discovery to design and evaluate new medicines.
Connecticut Innovations	88	Biotechnology, Business Development, Energy, Information Technology, Media and Entertainment, Venture Capital	Rocky Hill, Connecticut, United States	Connecticut Innovations provides strategic capital and operational insight to to companies in high-tech industries
Humacyte	88	Biotechnology, Medical, Medical Device	Morrisville, North Carolina, United States	Humacyte develops products for vascular diseases and replacement of anatomical conduits.
Neuralink	89	Artificial Intelligence (AI), Biotechnology, Health Care, Medical, Neuroscience, Robotics	Fremont, California, United States	Neuralink is a neurotechnology company that focuses on developing brain-computer interfaces designed to treat neurological disorders.
Firefly Bio	85	Biotechnology, Life Science, Medical	San Francisco, California, United States	Firefly Bio is a biotechnology company that develops targeted cancer therapeutics based on antibody-drug conjugate (ADC) technology.
Kardigan	90	Artificial Intelligence (AI), Biopharma, Health Care, Medical	South San Francisco, California, United States	Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.